Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Genetically engineered oncolytic Newcastle disease virus effectively induces sustained remission of malignant pleural mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, Newcastle Disease Virus /von 2010-09-21 / Mol. Cancer Ther. 2010 Oct;9(10):2761-9Measurement and mathematical modeling of thermally induced injury and heat shock protein expression kinetics in normal and cancerous prostate cells
/in Hyperthermia, International Publications, Prostate Cancer /von 2010-09-21 / Int J Hyperthermia 2010;26(8):748-64IFN{gamma} markedly cooperates with intratumoral dendritic cell vaccine in dog tumor models
/in Dendritic Cells, International Publications /von 2010-09-07 / Cancer Res. 2010 Sep;70(18):7093-101Dendritic cell vaccination of patients with metastatic colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2010-09-01 / Dan Med Bull 2010 Sep;57(9):B4171Harnessing naturally occurring tumor immunity: a clinical vaccine trial in prostate cancer
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-09-01 / PLoS ONE 2010 Sep;5(9)Immunological response after therapeutic vaccination with WT1 mRNA-loaded dendritic cells in end-stage endometrial carcinoma
/in Dendritic Cells, Endometrial Cancer, International Publications /von 2010-09-01 / Anticancer Res 2010 Sep;30(9):3709-14Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-08-24 / Clin. Cancer Res. 2010 Oct;16(20):5067-78Dendritic cells-mediated CTLs targeting hepatocellular carcinoma stem cells
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2010-08-22 / Cancer Biol. Ther. 2010 Aug;10(4):368-75The hemagglutinin-neuraminidase gene of Newcastle Disease Virus: a powerful molecular adjuvant for DNA anti-tumor vaccination
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2010-08-13 / Vaccine 2010 Oct;28(42):6891-900Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs
/in International Publications, Micronutrients /von 2010-08-08 / Cancer Chemother. Pharmacol. 2011 May;67(5):1157-66Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy
/in Dendritic Cells, International Publications /von 2010-08-01 / BioSystems 2010 Aug;101(2):117-26[Auto-dendritic cell vaccines pulsed with PSA, PSMA and PAP peptides for hormone-refractory prostate cancer]
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-08-01 / Zhonghua Nan Ke Xue 2010 Aug;16(8):698-704Prostate cancer as a model for tumour immunotherapy
/in Dendritic Cells, International Publications, Prostate Cancer /von 2010-08-01 / Nat. Rev. Immunol. 2010 Aug;10(8):580-93[Progress in using Newcastle disease virus for tumor therapy: a review]
/in International Publications, Newcastle Disease Virus /von 2010-08-01 / Sheng Wu Gong Cheng Xue Bao 2010 Aug;26(8):1031-6[Anti-tumor immunity of Newcastle disease virus HN protein is influenced by differential subcellular targeting]
/in International Publications, Newcastle Disease Virus /von 2010-08-01 / Zhongguo Fei Ai Za Zhi 2010 Aug;13(8):773-6Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway
/in Hyperthermia, International Publications, Newcastle Disease Virus, Pancreatic Cancer /von 2010-08-01 / Surgery 2010 Aug;148(2):325-34Dendritic cell vaccination in human melanoma: relationships between clinical effects and vaccine parameters
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-07-27 / Pigment Cell Melanoma Res 2010 Oct;23(5):607-19Human myeloid dendritic cells for cancer therapy: does maturation matter?
/in Dendritic Cells, International Publications /von 2010-07-19 / Vaccine 2010 Jul;28(32):5153-60Induction of complete and molecular remissions in acute myeloid leukemia by Wilms‘ tumor 1 antigen-targeted dendritic cell vaccination
/in Acute Leukemia, Dendritic Cells, International Publications /von 2010-07-14 / Proc. Natl. Acad. Sci. U.S.A. 2010 Aug;107(31):13824-9Optimizing dendritic cell-based immunotherapy in multiple myeloma: intranodal injections of idiotype-pulsed CD40 ligand-matured vaccines led to induction of type-1 and cytotoxic T-cell immune responses in patients
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2010-07-07 / Br. J. Haematol. 2010 Sep;150(5):554-64